Synthesis, structure–activity relationship of novel substituted 4H-chromen-1,2,3,4-tetrahydropyrimidine-5-carboxylates as potential anti-mycobacterial and anticancer agents
作者:B. China Raju、R. Nageswara Rao、P. Suman、P. Yogeeswari、D. Sriram、Thokhir Basha Shaik、Shasi Vardhan Kalivendi
DOI:10.1016/j.bmcl.2011.03.079
日期:2011.5
neuroblastoma cell line; amongst them the compound 7v is most effective compared to the standard drug Doxorubicin. This is the first report assigning in vitro anti-mycobacterial, anticancer and structure–activity relationship for this new class of 4H-chromen-1,2,3,4-tetrahydropyrimidine-5-carboxylates.
合成了一系列4 H -1,2,3,4-四氢嘧啶-5-羧甲基铬衍生物7a - 7zb,8a - 8d和9a - 9d并筛选了其对结核分枝杆菌H 37 Rv的体外抗分枝杆菌活性。(MTB)和针对三种人类癌细胞系(包括A549,SK-N-SH和HeLa)的细胞毒性。结果表明,六种化合物的效价更高,而7za与标准药物乙胺丁醇和环丙沙星相比,它是最有效的抗分枝杆菌衍生物。但是,有12种化合物对人神经母细胞瘤细胞系表现出细胞毒性。其中,与标准药物阿霉素相比,化合物7v最有效。这是首次针对这种新型的4 H -chromen-1,2,3,4-tetrahydropyrimidine-5-carboxylates分配体外抗分枝杆菌,抗癌和结构-活性关系的报告。